DRKS00032442已完成Unknown
Effects of bolus insulin dose reduction on time in range during postprandial exercise with hybrid closed-loop insulin delivery (CamAPS FX) in children and adolescents with type 1 diabetes - A randomized controlled crossover trial - InLoop
niversität Bayreuth0 个研究点目标入组 15 人开始时间: 2023年8月8日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 8 Years 至 17 Years（—）
- 性别
- All
入选标准
- •Informed consent obtained (provided from parent or legal guardian).
- •- Male or female aged 8-17 years (both inclusive).
- •- Diagnosed with type 1 diabetes mellitus (>12 months).
- •- Use of a hybrid-closed loop insulin delivery system (mylife CamAPS FX).
- •- Body mass index between the 10th and 90th percentile for the respective sex and age for children in Germany.
排除标准
- •- Simultaneous enrolment in any other study.
- •- Known or suspected hypersensitivity to trial products or related products.
- •- Receipt of any investigational medicinal product within 1 week prior to screening in this trial.
- •- Suffering from or history of a life-threatening disease (i.e. cancer judged not to be in full remission except basal cell skin cancer or squamous cell skin cancer), or clinically severe diseases that directly influence the study results, as judged by the Investigator. This does not prohibit the participation of patients taking medications that influence the metabolism (e.g. statin) or cardio-respiratory system (e.g. asthma spray) as long as the therapy is stable and not adapted throughout the run of the trial. Furthermore, it does not excluded patients who have celiac disease (or similar diseases or allergies), as long as the disease is stable, and patients are able to stay on their specific diet, e.g. gluten-free.
- •- Heart rate <35 beats per minute after resting for 5 min in supine position at screening
- •- Blood pressure outside the range of 90-150 mmHg for systolic or 50-95 mmHg for diastolic after resting for 5 min in supine position at screening (excluding white-coat hypertension; therefore, if a repeated measurement on a second screening visit shows values within the range, the participant can be included in the trial). This exclusion criterion also pertains to participants being on anti-hypertensives.
- •- Significant abnormal ECG at screening, as judged by the medical investigator.
- •- Any chronic (metabolic) disorder or severe disease besides type 1 diabetes mellitus which, in the opinion of the investigator, might jeopardize the participant’s safety or compliance with the protocol.
- •- History of multiple and/or severe allergies to drugs or foods or a history of severe anaphylactic reaction
- •- Participant with mental incapacity or language barriers including inadequate understanding or cooperation or who, in the opinion of their general practitioner or the investigator, should not participate in the trial
- •- Any condition that would interfere with trial participation or evaluation of results, as judged by the investigator
研究者
相似试验
尚未招募
Unknown
Impact of Insulin Bolus Reduction on Postprandial Blood Glucose Variations During Continuous and Intermittent Exercise in Patients with Type 1 DiabetesNutritional, Metabolic, EndocrinePACTR202304590853621repsss15
尚未招募
不适用
Comparison of two different techniques(insulin bolus vs glucose insulin infusion) to control blood glucose levels during surgeryCTRI/2017/12/011037Dr Arun P
已完成
不适用
Evaluation of long-acting insulin dose corresponding to lixisenatide dose in combination therapy of insulin and lixisenatideType 2 diabetes mellitusJPRN-UMIN000012024Kitano Hospital, The Tazuke Kofukai Medical Research Institute40
进行中（未招募）
不适用
Effekt av insulininfusion på sjukdomsförloppet vid infekterade fotsår samt vid thorax- och kärlkirurgi hos patienter med diabetesdiabetes mellitus infekterat fotsårkärl eller thoraxkirurgisk operationMedDRA version: 9.1Level: LLTClassification code 10012664Term: Diabetic foot ulcerMedDRA version: 9.1Level: LLTClassification code 10011090Term: Coronary artery surgeryMedDRA version: 9.1Level: LLTClassification code 10012601Term: Diabetes mellitusMedDRA version: 12.0Level: LLTClassification code 10048038Term: Wound infectionEUCTR2008-004537-19-SEKarolinska Universitetssjukhuset
已完成
3 期
This study aimed to determine the effects of insulin injection site and interval timing to the control of postprandial glucose in diabetes mellitus patients type 2Patient with diabetes type 2.Non-insulin-dependent diabetes mellitusE10-E14IRCT2017062134690N1Agus Santosa60